MERIT MEDICAL SYSTEMS INC
For the period ended Dec 31, 2025. Filed Feb 24, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 24, 2026
MMSI$87.81-0.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 15. Exhibits and Financial Statement Schedules
| (a) | Documents filed as part of this Report: |
|---|
| (1) | Financial Statements. The following consolidated financial statements and the notes thereto, and the Reports of Independent Registered Public Accounting Firm are incorporated by reference as provided in Item 8 and Item 9A of this report: |
Report of Independent Registered Public Accounting Firm (PCAOB ID 34) — Internal Control
Report of Independent Registered Public Accounting Firm — Financial Statements
Consolidated Balance Sheets as of December 31, 2025 and 2024
Consolidated Statements of Income for the Years Ended December 31, 2025, 2024 and 2023
Consolidated Statements of Comprehensive Income for the Years Ended December 31, 2025, 2024 and 2023
Consolidated Statements of Stockholders’ Equity for the Years Ended December 31, 2025, 2024 and 2023
Consolidated Statements of Cash Flows for the Years Ended December 31, 2025, 2024 and 2023
Notes to Consolidated Financial Statements
(2)Financial Statement Schedules.
Schedule II - Valuation and qualifying accounts
Years Ended December 31, 2025, 2024 and 2023
| · · · · · · · · · · · · | |||||
|---|---|---|---|---|---|
| · · · Balance at · · · Additions Charged to · · · · · · Balance at | |||||
| Allowance for Credit Losses: · · · Beginning of Year · · · Costs and Expenses (a) · · · Deduction (b) · · · End of Year | |||||
| 2023 | $(8,423) | $(1,772) | | $1,172 | $(9,023) |
| 2024 | $(9,023) | $(1,425) | | $719 | $(9,729) |
| 2025 | $(9,729) | $(2,964) | | $2,557 | $(10,136) |
| (a) | We record a provision for credit losses based upon historical bad debt experience, current economic conditions, expectations of future economic conditions, and management’s evaluation of our ability to collect individual outstanding balances. |
| (b) | When an individual customer balance becomes impaired and is deemed uncollectible, a deduction is made against the allowance for credit losses. |
Years Ended December 31, 2025, 2024 and 2023
| · · · · · · · · · · · · | |||||
|---|---|---|---|---|---|
| · · · Balance at · · · Additions Charged to · · · · · · Balance at | |||||
| Tax Valuation Allowance: · · · Beginning of Year · · · Costs and Expenses (a) · · · Deduction · · · End of Year | |||||
| 2023 | $(13,527) | $(213) | $ | - | $(13,740) |
| 2024 | $(13,740) | $(403) | $ | - | $(14,143) |
| 2025 | $(14,143) | $22 | $ | - | $(14,121) |
| (a) | We record a valuation allowance against a deferred tax asset when it is determined that it is more likely than not that the deferred tax asset will not be realized. |
| (b) | Exhibits: |
|---|
The following exhibits required by Item 601 of Regulation S-K are filed herewith or have been filed previously with the SEC as indicated below:
Index to Exhibits
| | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|
| · · · · Incorporated by Reference · | |||||||||
| Exhibit No. | | Exhibit Description | | Form | | Exhibit | | Filing Date | |
| | | | | | | | | | |
| 2.1 | | Asset Purchase Agreement, dated July 1, 2024, between Merit Medical Systems, Inc. and Endogastric Solutions, Inc.* | | 10-Q | | 2.1 | | August 1, 2024 | |
| | | | | | | | | | |
| 2.2 | | Asset Purchase Agreement, dated September 16, 2024, between Merit Medical Systems, Inc. and Cook Medical Holdings LLC.*# | | 10-Q | | 2.1 | | October 30, 2024 | |
| | | | | | | | | | |
| 2.3 | | Agreement and Plan of Merger among Merit Medical Systems, Inc., Biolife Transaction Sub, LLC, Biolife, L.L.C., and Shareholder Representative Services LLC, dated as of May 16, 2025.* | | 10-Q | | 2.1 | | July 30, 2025 | |
| | | | | | | | | | |
| 3.1 | | Second Amended and Restated Articles of Incorporation.* | | 10-Q | | 3.1 | | August 9, 2018 | |
| | | | | | | | | | |
| 3.2 | | Fourth Amended and Restated Bylaws.* | | 8-K | | 3.1 | | May 21, 2024 | |
| | | | | | | | | | |
| 4.1 | | Specimen Certificate of the Common Stock.* | | S-18 | | 10 | | October 19, 1989 | |
| | | | | | | | | | |
| 4.2 | | Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934. | | — | | — | | — | |
| | | | | | | | | | |
| 10.1 | | Lease Agreement, dated as of June 8, 1993, between QRS 11-20 (UT), Inc. and Merit Medical Systems, Inc. for office and manufacturing facility.* | | 10-K | | 10.4 | | March 31, 1995 | |
| | | | | | | | | | |
| 10.2 | | Amended and Restated Deferred Compensation Plan, dated January 1, 2004.*† | | 10-K | | 10.12 | | March 15, 2004 | |
| | | | | | | | | | |
| 10.3 | | Merit Medical Systems, Inc. Amended and Restated Deferred Compensation Plan, effective January 1, 2008.*† | | 8-K | | 10.1 | | December 18, 2008 | |
| | | | | | | | | | |
| 10.4 | | Second Restatement of the Merit Medical Systems, Inc. 401(k) Profit Sharing Plan, made and adopted effective May 31, 2009.*† | | 8-K | | 10.1 | | January 7, 2010 | |
| | | | | | | | | | |
| 10.5 | | First Amendment to the Second Restatement of the Merit Medical Systems, Inc. 401(k) Profit Sharing Plan, effective September 19, 2010.*† | | S-8 | | 4.9 | | August 11, 2015 | |
| | | | | | | | | | |
| 10.6 | | Second Amendment to the Second Restatement of the Merit Medical Systems, Inc. 401(k) Profit Sharing Plan, dated November 29, 2010.*† | | S-8 | | 4.10 | | August 11, 2015 | |
| | | | | | | | | | |
| 10.7 | | Third Amendment to the Second Restatement of the Merit Medical Systems, Inc. 401(k) Profit Sharing Plan, effective October 1, 2010.*† | | S-8 | | 4.11 | | August 11, 2015 | |
| | | | | | | | | | |
| 10.8 | | Fourth Amendment to the Second Restatement of the Merit Medical Systems, Inc. 401(k) Profit Sharing Plan, dated December 31, 2011.*† | | S-8 | | 4.12 | | August 11, 2015 | |
| | | | | | | | | | |
| 10.9 | | Fifth Amendment to the Second Restatement of the Merit Medical Systems, Inc. 401(k) Profit Sharing Plan, dated December 28, 2012.*† | | S-8 | | 4.13 | | August 11, 2015 | |
| | | | | | | | | | |
| 10.10 | | Sixth Amendment to the Second Restatement of the Merit Medical Systems, Inc. 401(k) Profit Sharing Plan, dated December 31, 2013.*† | | S-8 | | 4.14 | | August 11, 2015 | |
| | | | | | | | | | |
| 10.11 | | Seventh Amendment to the Second Restatement of the Merit Medical Systems, Inc. 401(k) Profit Sharing Plan, dated June 10, 2014.*† | | 10-Q | | 10.1 | | August 11, 2014 | |
| | | | | | | | | | |
| 10.12 | | Eighth Amendment to the Second Restatement of the Merit Medical Systems, Inc. 401(k) Profit Sharing Plan, dated December 29, 2014.*† | | S-8 | | 4.16 | | August 11, 2015 | |
| | | | | | | | | | |
| 10.13 | | Employment Agreement, dated May 26, 2016 between Merit Medical Systems, Inc. and Brian G. Lloyd.*† | | 10-Q | | 10.3 | | August 8, 2016 | |
| | | | | | | | | | |
| 10.14 | | Merit Medical Systems, Inc., Restatement of the 1996 Employee Stock Purchase Plan dated July 1, 2000.*† | | 10-K | | 10.23 | | March 1, 2017 | |
| | | | | | | | | | |
| 10.15 | | First Amendment to the Merit Medical Systems, Inc., 1996 Employee Stock Purchase Plan dated April 1, 2001.*† | | 10-K | | 10.24 | | March 1, 2017 | |
| | | | | | | | | | |
| 10.16 | | Second Amendment to the Merit Medical Systems, Inc., 1996 Employee Stock Purchase Plan dated January 1, 2006.*† | | 10-K | | 10.25 | | March 1, 2017 | |
| | | | | | | | | | |
| 10.17 | | Third Amendment to the Merit Medical Systems, Inc., 1996 Employee Stock Purchase Plan dated April 7, 2006.*† | | 10-K | | 10.26 | | March 1, 2017 | |
| | | | | | | | | | |
| 10.18 | | Fourth Amendment to the Merit Medical Systems, Inc., 1996 Employee Stock Purchase Plan dated February 13, 2015.*† | | 10-K | | 10.27 | | March 1, 2017 | |
| | | | | | | | | | |
| 10.19 | | Fifth Amendment to the Merit Medical Systems, Inc., 1996 Employee Stock Purchase Plan dated April 15, 2021.*† | | 10-Q | | 10.3 | | August 6, 2021 | |
| | | | | | | | | | |
| 10.20 | | First Amendment to Employment Agreement, dated December 11, 2017, between Merit Medical Systems, Inc. and Brian G. Lloyd.*† | | 8-K | | 10.3 | | December 15, 2017 | |
| | | | | | | | | | |
| 10.21 | | First Amendment to Lease Agreement dated May 22, 2017 for office and manufacturing facility.* | | 10-K | | 10.29 | | March 1, 2018 | |
| | | | | | | | | | |
| 10.22 | | Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan effective May 24, 2018.*† | | S-8 | | 4.2 | | June 4, 2018 | |
| | | | | | | | | | |
| 10.23 | | First Amendment to the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan effective December 14, 2018.*† | | 10-K | | 10.32 | | March 1, 2019 | |
| | | | | | | | | | |
| 10.24 | | Second Amendment to the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan effective April 15, 2021.*† | | 10-Q | | 10.2 | | August 6, 2021 | |
| | | | | | | | | | |
| 10.25 | | Employment Agreement made and entered into between Merit Medical Systems, Inc. and Raul Parra as of the 1st day of August, 2018.*† | | 10-Q | | 10.3 | | August 9, 2018 | |
| | | | | | | | | | |
| 10.26 | | Merit Medical Systems, Inc. 2019 Executive Bonus Plan, dated January 1, 2019.*† | | 10-Q | | 10.2 | | May 3, 2019 | |
| | | | | | | | | | |
| 10.27 | | Ninth Amendment to the Second Restatement of the Merit Medical Systems, Inc. 401(k) Profit Sharing Plan, dated August 1, 2016.*† | | 10-Q | | 10.1 | | August 9, 2019 | |
| | | | | | | | | | |
| 10.28 | | Tenth Amendment to the Second Restatement of the Merit Medical Systems, Inc. 401(k) Profit Sharing Plan, dated January 1, 2017.*† | | 10-Q | | 10.2 | | August 9, 2019 | |
| | | | | | | | | | |
| 10.29 | | Eleventh Amendment to the Second Restatement of the Merit Medical Systems, Inc. 401(k) Profit Sharing Plan, dated January 1, 2019.*† | | 10-Q | | 10.3 | | August 9, 2019 | |
| | | | | | | | | | |
| 10.30 | | Twelfth Amendment to the Second Restatement of the Merit Medical Systems, Inc. 401(k) Profit Sharing Plan, dated June 1, 2018.*† | | 10-Q | | 10.4 | | August 9, 2019 | |
| | | | | | | | | | |
| 10.31 | | Thirteenth Amendment to the Second Restatement of the Merit Medical Systems, Inc. 401(k) Profit Sharing Plan, effective January 1, 2019.*† | | 10-K | | 10.48 | | March 2, 2020 | |
| | | | | | | | | | |
| 10.32 | | First Amendment to the Merit Medical Systems, Inc. 2019 Executive Bonus Plan, effective June 22, 2020.*† | | 8-K | | 10.3 | | June 26, 2020 | |
| | | | | | | | | | |
| 10.33 | | Settlement Agreement, dated October 13, 2020, among the United States of America, acting through the United States Department of Justice and on behalf of the Office of Inspector General (“OIG-HHS”) of the Department of Health and Human Services (“HHS”), and the Defense Health Agency (“DHA”), acting on behalf of the TRICARE Program (collectively, the “United States”); Merit Medical Systems, Inc.; and Charles J. Wolf, M.D. (“Relator”), through their authorized representatives.* | | 8-K | | 10.1 | | October 16, 2020 | |
| | | | | | | | | | |
| 10.34 | | Form of Indemnification Agreement, dated October 24, 2020, between Merit Medical Systems, Inc. and each of the following individuals: F. Ann Millner, Ed. D., Lynne N. Ward, and Thomas J. Gunderson.*† | | 10-K | | 10.49 | | March 1, 2021 | |
| | | | | | | | | | |
| 10.35 | | Form of Indemnification Agreement, dated October 24, 2020, between Merit Medical Systems, Inc. and each of the following individuals: Lonny J. Carpenter, and David K. Floyd.*† | | 10-K | | 10.50 | | March 1, 2021 | |
| | | | | | | | | | |
| 10.36 | | Form of Indemnification Agreement between Merit Medical Systems, Inc. and each executive officer.*† | | 10-K | | 10.51 | | March 1, 2021 | |
| | | | | | | | | | |
| 10.37 | | Indemnification Agreement, dated as of June 17, 2021, between Merit Medical Systems, Inc. and Stephen C. Evans.*† | | 10-Q | | 10.1 | | October 28, 2022 | |
| | | | | | | | | | |
| 10.38 | | Form of Indemnification Agreement, dated as of May 19, 2022, between Merit Medical Systems, Inc. and each of Laura Kaiser and Michael McDonnell.*† | | 10-Q | | 10.2 | | October 28, 2022 | |
| | | | | | | | | | |
| 10.39 | | Employment Agreement between Merit Medical Systems, Inc. and Michel J. Voigt, dated December 11, 2020.*† | | 10-K | | 10.53 | | March 1, 2021 | |
| | | | | | | | | | |
| 10.40 | | Employment Agreement between Merit Medical Systems, Inc. and Neil Peterson, dated May 19, 2022.*† | | 10-K | | 10.51 | | February 24, 2023 | |
| | | | | | | | | | |
| 10.41 | | Second Amendment to Lease Agreement dated March 10, 2022, between MM (UT) QRS 11-59, Inc. and Merit Medical Systems, Inc. for office and manufacturing facility.* | | 10-K | | 10.61 | | February 24, 2023 | |
| | | | | | | | | | |
| 10.42 | | Deferred Compensation Plan for Non-Employee Directors, effective as of July 22, 2022.*† | | 10-Q | | 10.1 | | August 5, 2022 | |
| | | | | | | | | | |
| 10.43 | | Performance Stock Unit Award Agreement (Three Year Performance Period), dated February 28, 2023, between Merit Medical Systems, Inc. and Fred Lampropoulos.*† | | 10-Q | | 10.1 | | April 28, 2023 | |
| | | | | | | | | | |
| 10.44 | | Form of Performance Stock Unit Award Agreement (Three Year Performance Period), dated February 28, 2023, between Merit Medical Systems, Inc. and each of the following individuals: Raul Parra, Neil Peterson, Brian G. Lloyd, and Michel J. Voigt.*† | | 10-Q | | 10.2 | | April 28, 2023 | |
| | | | | | | | | | |
| 10.45 | | Performance Stock Unit Award Agreement (Three Year Performance Period), dated March 4, 2024, between Merit Medical Systems, Inc. and Fred Lampropoulos.*† | | 10-Q | | 10.3 | | April 30, 2024 | |
| | | | | | | | | | |
| 10.46 | | Form of Performance Stock Unit Award Agreement (Three Year Performance Period), dated March 4, 2024, between Merit Medical Systems, Inc. and each of the following individuals: Raul Parra, Neil Peterson, and Brian Lloyd.*† | | 10-Q | | 10.4 | | April 30, 2024 | |
| | | | | | | | | | |
| 10.47 | | Performance Stock Unit Award Agreement (Three Year Performance Period), dated March 4, 2024, between Merit Medical Systems, Inc. and Mike Voigt.*† | | 10-Q | | 10.5 | | April 30, 2024 | |
| | | | | | | | | | |
| 10.48 | | Restricted Stock Unit Award Agreement, dated March 9, 2024, between Merit Medical Systems, Inc. and Fred Lampropoulos.*† | | 10-Q | | 10.6 | | April 30, 2024 | |
| | | | | | | | | | |
| 10.49 | | Form of Restricted Stock Unit Award Agreement, dated March 4, 2024, between Merit Medical Systems, Inc. and each of the following individuals: Raul Parra, Neil Peterson, and Brian Lloyd.*† | | 10-Q | | 10.7 | | April 30, 2024 | |
| | | | | | | | | | |
| 10.50 | | Restricted Stock Unit Award Agreement, dated March 8, 2024, between Merit Medical Systems, Inc. and Mike Voigt.*† | | 10-Q | | 10.8 | | April 30, 2024 | |
| | | | | | | | | | |
| 10.51 | | Indemnification Agreement, dated May 15, 2024, between Merit Medical Systems, Inc. and Silvia M. Perez.* | | 8-K | | 10.1 | | May 21, 2024 | |
| | | | | | | | | | |
| 10.52 | | Performance Stock Unit Award Agreement (Three Year Performance Period), dated February 28, 2025, between Merit Medical Systems, Inc. and Fred Lampropoulos.*† | | 10-Q | | 10.3 | | April 24, 2025 | |
| | | | | | | | | | |
| 10.53 | | Performance Stock Unit Award Agreement (Three Year Performance Period), dated February 28, 2025, between Merit Medical Systems, Inc. and Raul Parra.*† | | 10-Q | | 10.4 | | April 24, 2025 | |
| | | | | | | | | | |
| 10.54 | | Performance Stock Unit Award Agreement (Three Year Performance Period), dated February 28, 2025, between Merit Medical Systems, Inc. and Brian Lloyd.*† | | 10-Q | | 10.5 | | April 24, 2025 | |
| | | | | | | | | | |
| 10.55 | | Performance Stock Unit Award Agreement (Three Year Performance Period), dated February 28, 2025, between Merit Medical Systems, Inc. and Neil Peterson.*† | | 10-Q | | 10.6 | | April 24, 2025 | |
| | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|
| 10.56 | | Performance Stock Unit Award Agreement (Three Year Performance Period), dated February 28, 2025, between Merit Medical Systems, Inc. and Mike Voigt.*† | | 10-Q | | 10.7 | | April 24, 2025 | |
| | | | | | | | | | |
| 10.57 | | Restricted Stock Unit Award Agreement, dated February 28, 2025, between Merit Medical Systems, Inc. and Fred Lampropoulos.*† | | 10-Q | | 10.8 | | April 24, 2025 | |
| | | | | | | | | | |
| 10.58 | | Restricted Stock Unit Award Agreement, dated February 28, 2025, between Merit Medical Systems, Inc. and Raul Parra.*† | | 10-Q | | 10.9 | | April 24, 2025 | |
| | | | | | | | | | |
| 10.59 | | Restricted Stock Unit Award Agreement, dated February 28, 2025, between Merit Medical Systems, Inc. and Brian Lloyd.*† | | 10-Q | | 10.10 | | April 24, 2025 | |
| | | | | | | | | | |
| 10.60 | | Restricted Stock Unit Award Agreement, dated February 28, 2025, between Merit Medical Systems, Inc. and Neil Peterson.*† | | 10-Q | | 10.11 | | April 24, 2025 | |
| | | | | | | | | | |
| 10.61 | | Restricted Stock Unit Award Agreement, dated February 28, 2025, between Merit Medical Systems, Inc. and Mike Voigt.*† | | 10-Q | | 10.12 | | April 24, 2025 | |
| | | | | | | | | | |
| 10.62 | | Form of Restricted Stock Unit Award Agreement, dated May 15, 2025, between Merit Medical Systems, Inc. and each of the following individuals: Lonny J. Carpenter, Stephen C. Evans, David K. Floyd, Thomas J. Gunderson, Laura S. Kaiser, Michael R. McDonnell, F. Ann Millner, Silvia M. Perez and Lynne N. Ward.*† | | 10-Q | | 10.1 | | July 30, 2025 | |
| | | | | | | | | | |
| 10.63 | | Performance Stock Unit Award Agreement (Three Year Performance Period), dated October 3, 2025, between Merit Medical Systems, Inc. and Martha G. Aronson.*† | | 10-Q | | 10.2 | | October 30, 2025 | |
| | | | | | | | | | |
| 10.64 | | Restricted Stock Unit Award Agreement, dated October 3, 2025, between Merit Medical Systems, Inc. and Martha G. Aronson.*† | | 10-Q | | 10.3 | | October 30, 2025 | |
| | | | | | | | | | |
| 10.65 | | Chief Executive Officer Employment Agreement, dated October 3, 2025, between Merit Medical Systems, Inc. and Martha G. Aronson.*† | | 10-Q | | 10.1 | | October 30, 2025 | |
| | | | | | | | | | |
| 10.66 | | Indemnification Agreement, dated October 3, 2025, between Merit Medical Systems, Inc. and Martha G. Aronson.† | | — | | — | | — | |
| | | | | | | | | | |
| 10.67 | | CEO Transition Agreement, dated October 3, 2025, between Merit Medical Systems, Inc. and Fred P. Lampropoulos.*† | | 10-Q | | 10.4 | | October 30, 2025 | |
| | | | | | | | | | |
| 10.68 | | Consulting Agreement, dated January 7, 2026, between Merit Medical Systems, Inc. and Fred P. Lampropoulos.†# | | — | | — | | — | |
| | | | | | | | | | |
| 10.69 | | Employment Agreement, dated September 1, 2025, between Merit Medical Systems, Inc. and Christian Adam Smith.*† | | 10-Q | | 10.5 | | October 30, 2025 | |
| | | | | | | | | | |
| 10.70 | | Indemnification Agreement, dated September 1, 2025, between Merit Medical Systems, Inc. and Christian Adam Smith.*† | | 10-Q | | 10.6 | | October 30, 2025 | |
| | | | | | | | | | |
| 10.71 | | Performance Stock Unit Award Agreement (Three Year Performance Period), dated February 28, 2025, between Merit Medical Systems, Inc. and Christian Adam Smith.† | | — | | — | | — | |
| | | | | | | | | | |
| 10.72 | | Restricted Stock Unit Award Agreement, dated February 28, 2025, between Merit Medical Systems, Inc. and Christian Adam Smith.† | | — | | — | | — | |
| | | | | | | | | | |
| 10.73 | | Restricted Stock Unit Award Agreement, dated May 22, 2025, between Merit Medical Systems, Inc. and Christian Adam Smith.† | | — | | — | | — | |
| | | | | | | | | | |
| 10.74 | | Fourth Amended and Restated Credit Agreement, dated June 6, 2023, among Merit Medical Systems, Inc. as Borrower and the Lenders referred to therein, as Lenders, and Wells Fargo Bank, National Association, as Administrative Agent, and Wells Fargo Securities, LLC, BOFA Securities, Inc., HSBC Bank USA, National Association, U.S. Bank National Association and Truist Securities, Inc., as Joint Lead Arrangers and Joint Bookrunners, and Bank of America, N.A., HSBC Bank USA, National Association, U.S Bank National Association and Truist Bank as Co-Syndication Agents and TD Bank, N.A., as Documentation Agent.* | | 10-Q | | 10.2 | | July 28, 2023 | |
| | | | | | | | | | |
| 10.75 | | Amended and Restated Employment Agreement, dated June 8, 2023, between Merit Medical Systems, Inc. and Fred P. Lampropoulos.* | | 8-K | | 99.3 | | June 8, 2023 | |
| | | | | | | | | | |
| 10.76 | | Indenture, dated as of December 8, 2023, among Merit Medical Systems, Inc., and U.S. Bank Trust Company, National Association, as trustee.* | | 8-K | | 4.1 | | December 8, 2023 | |
| | | | | | | | | | |
| 10.77 | | Form of 3.00% Convertible Senior Note due 2029.* | | 8-K | | 4.2 | | December 8, 2023 | |
| | | | | | | | | | |
| 10.78 | | Form of Capped Call Confirmation.* | | 8-K | | 10.1 | | December 8, 2023 | |
| | | | | | | | | | |
| 10.79 | | First Amendment to the Fourth Amended and Restated Credit Agreement dated December 5, 2023, among certain subsidiaries of Merit Medical Systems, Inc., Wells Fargo Bank, National Association, as administrative agent for Lenders, Bank of America, N.A., HSBC Bank USA, National Association, U.S. Bank National Association, Truist Bank, TD Bank, N.A., Huntington National Bank, and Regions Bank. | | 10-K | | 10.68 | | February 28, 2024 | |
| | | | | | | | | | |
| 10.80 | | Rule 10b5-1 Trading Plan, dated August 7, 2023, between F. Ann Millner and ETRADE Securities LLC. | | 10-K | | 10.69 | | February 28, 2024 | |
| | | | | | | | | | |
| 10.81 | | Rule 10b5-1 Trading Plan, dated March 11, 2024, between Neil W. Peterson and Morgan Stanley Smith Barney LLC.* | | 10-Q | | 10.1 | | April 30, 2024 | |
| | | | | | | | | | |
| 10.82 | | Rule 10b5-1 Trading Plan, dated March 15, 2024, between Raul Parra and Morgan Stanley Smith Barney LLC.* | | 10-Q | | 10.2 | | April 30, 2024 | |
| | | | | | | | | | |
| 10.83 | | Rule 10b5-1 Trading Plan, dated November 6, 2024, between Neil W. Peterson and Morgan Stanley Smith Barney LLC.* | | 10-K | | 10.78 | | February 25, 2025 | |
| | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|
| 10.84 | | Rule 10b5-1 Trading Plan, dated February 28, 2025, between David K. Floyd and Charles Schwab & Co., Inc.* | | 10-Q | | 10.1 | | April 24, 2025 | |
| | | | | | | | | | |
| 10.85 | | Rule 10b5-1 Trading Plan, dated February 28, 2025, between Michael R. McDonnell and Morgan Stanley Smith Barney LLC.* | | 10-Q | | 10.2 | | April 24, 2025 | |
| | | | | | | | | | |
| 19.1 | | Corporate Policy on Insider Trading (revised May 15, 2025)* | | 10-Q | | 19.1 | | July 30, 2025 | |
| | | | | | | | | | |
| 21 | | Subsidiaries of Merit Medical Systems, Inc. | | — | | — | | — | |
| | | | | | | | | | |
| 23.1 | | Consent of Independent Registered Public Accounting Firm. | | — | | — | | — | |
| | | | | | | | | | |
| 31.1 | | Certification of Chief Executive Officer. | | — | | — | | — | |
| | | | | | | | | | |
| 31.2 | | Certification of Chief Financial Officer. | | — | | — | | — | |
| | | | | | | | | | |
| 32.1 | | Certification of Chief Executive Officer. | | — | | — | | — | |
| | | | | | | | | | |
| 32.2 | | Certification of Chief Financial Officer. | | — | | — | | — | |
| | | | | | | | | | |
| 97 | | Policy Relating to the Recovery of Erroneously Awarded Compensation.*† | | 10-K | | 97 | | February 28, 2024 | |
| | | | | | | | | | |
| 101 | | The following materials from the Merit Medical Systems, Inc. Annual Report on Form 10-K for the fiscal year ended December 31, 2025, formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) Consolidated Statements of Income, (ii) Consolidated Statements of Comprehensive Income, (iii) Consolidated Balance Sheets, (iv) Consolidated Statements of Cash Flows, (v) Consolidated Statements of Equity, and (vi) Notes to Consolidated Financial Statements. | | — | | — | | — | |
| | | | | | | | | | |
| 104 | | Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document). | | — | | — | | — | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| * | These exhibits are incorporated herein by reference. |
|---|
| † | Indicates management contract or compensatory plan or arrangement. |
|---|
| # | Portions of this exhibit have been omitted. |
|---|
| (c) | Schedules: |
|---|
None
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.